OK for third dose of Pfizer's COVID-19 vaccine could come Friday

As immunocompromised Marylanders roll up their sleeves for a booster shot of the COVID-19 vaccine, a federal advisory panel is slated to meet Friday to decide whether everyone else should get booster shots, too. A big batch of COVID-19 booster shot data from Pfizer's vaccine is in, and its review is on the calendar Friday at the Food and Drug Administration. That's when an outside advisory panel for the agency will meet to discuss, debate and decide whether to authorize a third dose of Pfizer's vaccine to people 16 and older.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting